18. Pharmacology of Agents Used in the Treatment of MI Flashcards

1
Q

What are 8 Drugs that can be used in the Treatment of Myocardial Infarction?

Examples of each?

A

Drug Treatment of Myocardial Infarction

  1. Plasminogen activators - e.g. alteplase
  2. Anticoagulants - e.g. heparin
  3. Antiplatelet medications - e.g. aspirin, clopidogrel
  4. Organic nitrates - e.g. glyceryl trinitrate
  5. Strong analgesics - e.g. morphine
  6. Beta blockers - e.g. metoprolol
  7. ACE inhibitors - e.g. ramipril (or an angiotensin II receptor antagonist)
  8. Statins - e.g. atorvastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an Acute Coronary Syndrome?

What are 3 types of ACS?

A

Acute Coronary Syndrome

  • An acute coronary syndrome (ACS) occurs when there is a significant decrease in coronary blood flow leading to acute myocardial ischaemia
  • 3 Types:
    1. Unstable Angina → anginal pain which occurs with less and less exertion, and ultimately at rest
    2. STEMI → sudden and complete block of a coronary artery causing full thickness damage of the ventricular wall (transmural)
    3. NSTEMI → severely narrowed, but not completely blocked coronary artery (similar to unstable angina)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Plasminogen Activators

  • 3 Examples?
  • Mechanism of Action?
  • Indications?
  • Adverse Effects?
A

Plasminogen Activators

  • Examples
    1. Alteplase
    2. Reteplase
    3. Tenecteplase
  • Mechanism of Action
    • They convert plasminogen to plasmin
    • Plasmin breaks down fibrin (fibrinolytic effect) which results in degradation of the thrombus
  • Indications
    • Used in the acute treatment of occlusive coronary artery disease and myocardial infarction (STEMI)
    • Initiated within 6 to 12 hours of onset of symptoms
  • Adverse Effects
    • May produce bleeding and haemorrhage, which can be life threatening (e.g. intracranial, gastrointestinal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Alteplase and how does it work?

A

Plasminogen Activators - Alteplase

  • Alteplase = a serine protease tissue plasminogen activator in the presence of fibrin
  • Alteplase binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin
  • This initiates local fibrinolysis (thrombolysis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 2 examples of Anticoagulants?

A

Anticoagulants - Examples

  1. Heparin
  2. Warfarin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Heparin and how does it work?

What does it combine with?

Which 2 clotting factors does it inhibit?

A

Anticoagulants - Heparin

  • Antithrombin III is a glycoprotein which mainly inhibits the activity of thrombin (IIa) and activated factor X (Xa)
  • Heparin exerts an anticoagulant effect by combining with antithrombin III and enhancing the rate at which antithrombin III inhibits thrombin (IIa) and activated factor X (Xa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Warfarin and how does it work?

What does it inhibit the synthesis of? (which 4 clotting factors)

A

Anticoagulants - Warfarin

  • Is a coumarin anticoagulant which inhibits the synthesis of vitamin K dependent clotting factors
  • Vitamin K dependent clotting factors are factors II, VII, IX and X
  • Inhibits the vitamin K epoxide reductase (VKORC1) enzyme complex, which inhibits the reduction of vitamin K epoxide to its active hydroquinone form
  • The hydroquinone form is necessary for the carboxylation and activity of factors II, VII, IX and X
  • Does not directly inhibit factors II, VII, IX and X
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is the onset of warfarin’s anticoagulant activity is delayed?

A

Anticoagulants - Warfarin

  • Does not inhibit the activity of factors II, VII, IX and X formed and carboxylated prior to warfarin administration
  • Onset of anticoagulant activity is delayed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the ffect of warfarin is monitored by measuring?

What is the normal range?

A

Warfarin - International Normalised Ratio (INR)

  • The effect of warfarin is monitored by measuring the International Normalised Ratio (INR)
  • The INR target range for most conditions is 2-3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some of the newer anticoagulants and which clotting factor/molecule do they inhibit?

A

Newer Anticoagulants

  1. Apixaban → Factor Xa
  2. Rivaroxaban → Factor Xa
  3. Dabigatran → Thrombin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are Antiplatelet Medications and how do they work?

A

Antiplatelet Medications

  • Atherosclerotic plaque on the inside of blood vessel walls can precipitate the aggregation of platelets (plug formation) and thrombus formation
  • Antiplatelet drugs reduce thrombus formation by inhibiting platelet aggregation
  • Used to prevent atherothrombotic events such as myocardial infarction
  • Give all patients presenting with a STEMI dual antiplatelet therapy with aspirin and a P2Y12 inhibitor (clopidogrel, prasugrel, ticagrelor).
  • Examples: Lose Dose Aspirin, NSAIDs, Dipyridamole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are Organic Nitrates and how do they work?

A

Organic Nitrates

  • Organic nitrates e.g. glyceryl trinitrate are metabolised to nitric oxide (NO), in a reaction possibly involving sulfhydryl (SH) groups
  • Increase cyclic guanosine monophosphate levels (cGMP) and activate protein kinase G
  • Produce vascular smooth muscle relaxation
  • Relaxation of vascular smooth muscle produces vasodilation
  • Relax and dilate both arteries and veins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 3 reasons why Organic Nitrates are effective in the treatment of coronary syndromes?

A

Organic Nitrates - Are effective in the treatment of coronary syndromes because they:

  1. Cause venous dilation which reduces venous return and preload, and reduces cardiac work and oxygen demand
  2. Cause artery/arteriolar dilation which reduces peripheral resistance and afterload, and reduces cardiac work and oxygen demand
  3. Dilate coronary vessels and increase coronary blood flow, particularly to ischaemic areas, which increases myocardial oxygen supply
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are Beta Adrenoceptor Antagonists (Beta Blockers) and how do they work?

2 Types?

A

Beta Adrenoceptor Antagonists (Beta Blockers)

  • Beta adrenergic receptor antagonists competitively antagonise the actions of adrenaline and noradrenaline at beta adrenergic receptors
  • 2 types:
    • Non-selective
    • Selective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are Non-selective beta blockers?

1 Example?

A

Non-Selective Beta Blockers

Some are nonselective beta blockers which competitively antagonise the actions of adrenaline and noradrenaline at all adrenergic beta receptors - β1, β2 and β3 receptors

Example = propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are Selective/Cardio-selective Beta Blockers?

2 Examples?

A

Selective/Cardio-selective Beta Blockers

  • Some beta blockers are selective beta adrenergic receptor antagonists
  • They are competitive antagonists of adrenaline and noradrenaline at β1 receptors
  • They are known as selective, or cardio- selective, beta blockers
  • It is important to note that their selectivity is not absolute, and in high doses they may also block β2 and β3 adrenergic receptors

Examples = atenolol and metoprolol

17
Q

What role can Beta Blockers play in patients with MI?

A

Beta Adrenoceptor Antagonists (Beta Blockers)

  • Beta blockers are used in the treatment of myocardial infarction
  • Reduce the effects of the sympathetic nervous system on the heart
  • Exert an antidysrhythmic (antiarrhythmic) effect
  • Limit infarct size?
  • The benefit of beta-blocker therapy persists long term, and beta blockers should be continued indefinitely in high-risk patients
18
Q

When should you start an ACE inihibitor in a patient following an MI?

6 Indications?

A

ACE Inhibitors or Angiotensin II Receptor Antagonists

  • ACE inhibitors reduce cardiovascular mortality after MI
  • Unless contraindicated, start an ACEI within 24-48 hours of acute MI in patients with evidence of any of the following:
    1. Left ventricular failure or significant dysfunction
    2. Previous MI
    3. Diabetes
    4. Hypertension
    5. Anterior location of infarct on electrocardiogram (ECG)
    6. Elevated heart rate (>80 beats per minute).
  • ACE inhibitors limit infarct size, reduce ventricular remodelling and reduce cardiovascular mortality
  • Angiotensin II receptor antagonists if ACE inhibitor not tolerated